Session translationnelle #2 : Oncologie

mardi 11 juin 2024
Sessions translationnelles
Sessions translationnelles • S12 • 13h30 > 15h00 • Session translationnelle #2 : Oncologie • B124 Sessions translationnelles
Modérateurs : TBC

Conférence invitée
13h30 Apports de la Pharmacogénomique dans le traitement des cancers - Samia MOURAH (Paris)

Communications orales
• 7 • CO-007 - Deleterious association between Proton Pump Inhibitor and Protein Kinase Inhibitor exposure and survival for patients with lung cancer: a nationwide cohort study. > C. Constance Bordet • 136 • CO-008 - Impact of non-small cell lung cancer cell secretome on endothelial cell plasticity > C. Clara Bourreau • 158 • CO-009 - Can we identify patients carrying DPYD variants deficient with uracil and dihydrouracil? A GPCO-RNPGx retrospective analysis > M. Manon Launay • 209 • CO-010 - Rational use of herbal products in paediatric patients treated with anti-cancer drugs > D. Delphine Bourneau-Martin • 271 • CO-011 - Cetuximab pharmacokinetics mediated by both target antigen and crystallizable portion (Fc) mechanisms: A multitarget-mediated drug disposition (TMDD) mechanistic model. > I. Isaure Breteau • 341 • CO-012 - Pharmacokinetics of anti-CD19-targeted CAR T-cells in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients > D. David TERNANT

Copyright © key4events - All rights reserved